sefulness of change to anagliptin from other DPP-4 inhibitors in patients with uncontroled LDL-cholesterol
Not Applicable
- Conditions
- typr 2 diabetes hypercholesterolemia
- Registration Number
- JPRN-UMIN000012329
- Lead Sponsor
- Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
HbA1c > 8% LDL-cholesterol >= 160mg/dl history of colonary disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DL-cholesterol concentration
- Secondary Outcome Measures
Name Time Method